XML 67 R56.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENTS - Summarized Financial Information by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Segment Reporting Information [Abstract]          
Revenues $ 121,984 $ 107,191 $ 236,786 $ 189,066  
Cost of product revenue 54,757 49,738 108,463 92,505  
Research and development 1,031 560 1,858 1,010  
Plasma center operating expenses 1,152 942 2,438 1,947  
Amortization of intangible assets 32 142 57 335  
Consolidated selling, general and administrative expense 22,214 16,608 46,292 32,247  
Other expense, net (2,701) (3,350) (4,132) (6,770)  
Income (loss) before taxes 40,097 35,851 73,546 54,252  
Unallocated interest expense, primarily related to interest on senior debt (see Note 6) 1,834 3,783 3,809 7,552  
Unallocated interest income 400 449 1,008 833  
Loss on extinguishment of debt (1,159) 0 (1,159) 0  
Total assets 558,380 376,399 558,380 376,399 $ 488,678
Operating Segments [Member]          
Segment Reporting Information [Abstract]          
Revenues 121,948 107,155 236,715 188,995  
Cost of product revenue 54,757 49,738 108,463 92,505  
Research and development 1,031 560 1,858 1,010  
Plasma center operating expenses 1,152 942 2,438 1,947  
Selling, marketing and distribution 5,868 4,504 11,911 8,935  
Amortization of intangible assets 32 142 57 335  
General and administrative expense 14,941 5,791 30,024 11,140  
Other expense, net (108) (16) (172) (51)  
Income (loss) before taxes 44,059 45,462 81,792 73,072  
Expenditures for additions to long-lived assets 2,027 1,268 6,747 4,413  
Total assets 397,390 291,701 397,390 291,701  
Reconciling Item [Member]          
Segment Reporting Information [Abstract]          
Revenues 36 36 71 71  
Income (loss) before taxes 36 36 71 71  
Unallocated interest expense, primarily related to interest on senior debt (see Note 6) (1,834) (3,783) (3,809) (7,552)  
Unallocated interest income 400 449 1,008 833  
Loss on extinguishment of debt (1,159)   (1,159)    
Corporate [Member]          
Segment Reporting Information [Abstract]          
General and administrative expense [1] 1,405 6,313 4,357 12,172  
Income (loss) before taxes [1] (1,405) (6,313) (4,357) (12,172)  
Total assets [2] 160,990 84,698 160,990 84,698  
ADMA BioManufacturing [Member] | Operating Segments [Member]          
Segment Reporting Information [Abstract]          
Revenues 121,948 106,183 235,665 186,297  
Cost of product revenue 54,757 48,471 107,814 89,462  
Research and development 1,031 560 1,858 1,010  
Plasma center operating expenses 0 0 0 0  
Selling, marketing and distribution 5,868 4,504 11,911 8,935  
Amortization of intangible assets 32 142 57 335  
General and administrative expense 14,941 5,791 30,024 11,140  
Other expense, net (108) (13) (172) (47)  
Income (loss) before taxes 45,211 46,702 83,829 75,368  
Expenditures for additions to long-lived assets 2,034 1,210 6,733 4,338  
Total assets 368,229 258,094 368,229 258,094  
Plasma Collection Centers [Member] | Operating Segments [Member]          
Segment Reporting Information [Abstract]          
Revenues 0 972 1,050 2,698  
Cost of product revenue 0 1,267 649 3,043  
Research and development 0 0 0 0  
Plasma center operating expenses 1,152 942 2,438 1,947  
Selling, marketing and distribution 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
General and administrative expense 0 0 0 0  
Other expense, net 0 (3) 0 (4)  
Income (loss) before taxes (1,152) (1,240) (2,037) (2,296)  
Expenditures for additions to long-lived assets (7) 58 14 75  
Total assets $ 29,161 $ 33,607 $ 29,161 $ 33,607  
[1]
-
Primarily includes compensation expense, including stock-based compensation expense, for certain executive officers and consultants, insurance, legal and investor relations expenses and accounting and tax fees that are not allocated to the Company's operating segments.
[2]
-
Primarily consists of cash and deferred tax assets.